Results 111 to 120 of about 243,447 (308)

Immunoblot analysis of FLAG-BrBRI1 kinase phosphoprotein production over a time course.

open access: yes, 2015
Immunoblot analysis of FLAG-BrBRI1 kinase phosphoprotein production over a time course.
Vignesh Dhandapani (829058)   +6 more
core   +1 more source

A Decoy‐Receptor‐Armed Biomimetic Nanotherapeutic With Inherent Tropism for Conserved Pathogenic Macrophages for Treating Osteoarthritis and Intervertebral Disc Degeneration

open access: yesAdvanced Science, EarlyView.
A biomimetic doppelgänger nanosystem neutralizes extracellular inflammatory cytokines and silences intracellular pyroptosis, reprogramming pathogenic macrophages to attenuate both joint and spine degeneration. ABSTRACT Osteoarthritis (OA) and intervertebral disc degeneration (IVDD) are debilitating musculoskeletal disorders driven by shared ...
Fudong Li   +9 more
wiley   +1 more source

Basic demographic of patients with PLDS with results of the immunoblot for Lyme disease.

open access: yes, 2019
Basic demographic of patients with PLDS with results of the immunoblot for Lyme disease.
Peter Novak (5793923)   +4 more
core   +1 more source

SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury

open access: yesAdvanced Science, EarlyView.
MI/RI is a major clinical challenge with high morbidity and mortality. This study demonstrates that SR‐A3 expression is downregulated in MI/RI, and its deletion exacerbates damage via the USP18/ISG15/STING axis, revealing SR‐A3 as a potential therapeutic target.
Yufei Han   +24 more
wiley   +1 more source

Immunoblot analysis of V. harveyi chitoporin.

open access: yes, 2013
A–B: Cross-reactivity of VhChiP antiserum with other outer membrane porins. A. Coomassie blue-stained SDS-polyacrylamide gel, and B. The corresponding immunoblot detected with anti VhChiP antibody C–D: Cross-reactivity of VhChiP and E.
Kozhinjampara R. Mahendran (264133)   +5 more
core   +1 more source

A New Recruitable E3 Ligase UHRF1 Supporting Targeted Protein Degradation: A Minimal Azide as a Recruitment Ligand

open access: yesAdvanced Science, EarlyView.
Targeted protein degradation is often limited by the scarcity of usable E3 ligases. Herein, we report the first small‐molecule GPX4 degraders that incorporate either electrophilic warheads or a minimal azide group as an E3 recruitment ligand. The azide‐based degrader DK‐5070 effectively drives potent GPX4 degradation; mechanistic studies reveal that ...
Zehong Lin   +14 more
wiley   +1 more source

Immunoblot analysis of chloroplast subfractions and protein stability.

open access: yes, 2016
(A) Chloroplasts isolated from transgenic plants overexpressing PGL34-YFP were used to separate soluble (stromal) and membrane fractions. The latter were loaded in a sucrose density gradient and separated by ultracentrifugation.
Manuel Rodriguez-Concepcion (310794)   +6 more
core   +1 more source

Fzd7 Restrains Pink1‐Dependent Mitophagy in Suture Stem Cells to Maintain Cranial Suture Patency

open access: yesAdvanced Science, EarlyView.
How suture stem cells fail to preserve cranial suture patency remains incompletely understood. Integrated single‐cell and high‐resolution spatial transcriptomic analyses identify reduced Fzd7 expression in Prrx1+ suture stem cells as an early feature of craniosynostosis.
Xinyan Chen   +10 more
wiley   +1 more source

Characterization of mycobacterial antigens by Elisa and immunoblot methods.

open access: yes, 1995
Antibodies to two mycobacterial antigens viz - culture filtrate antigen (CFA) and Mycobacterium tuberculosis antigen 5 were raised in rabbits. Enzyme-linked immuno sorbent assay (ELISA) and immunoblot methods were used for the evaluation of the ...

core   +1 more source

TH17–Associated Polyamine Metabolism‐Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis

open access: yesAdvanced Science, EarlyView.
A pronounced TH17‐skewed immune response is identified in experimental periodontitis, and enrichment of the polyamine pathway is observed during TH17 differentiation, suggesting its potential as an immunometabolic target. Inspired by these findings, DFMO@Ui‐Mn is developed as a therapeutic platform combining cascade ROS scavenging with immunometabolic ...
Cheng Zhu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy